Jay Durga Enzymatic Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 7.00 Cr
- Revenue Growth -48.37%
- Profit Growth -45.79%
- Ebitda 14.23%
- Net Worth 15.70%
- Total Assets 10.69%
About Jay Durga Enzymatic
Jay Durga Enzymatic Private Limited (JDEPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 15 November 2012 and has a history of 12 years and two months. Its registered office is in Cuttack, Odisha, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹7.00 Cr.
Kailash Prusty and Manjulata Prusty serve as directors at the Company.
Company Details
-
Location
Cuttack, Odisha, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100OR2012PTC016226
-
Company No.
016226
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Nov 2012
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Jay Durga Enzymatic?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kailash Prusty
|
Managing Director | 15-Nov-2012 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Manjulata Prusty
|
Director | 15-Nov-2012 | Current |
Financial Performance of Jay Durga Enzymatic.
Jay Durga Enzymatic Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 48.37% decrease. The company also saw a substantial fall in profitability, with a 45.79% decrease in profit. The company's net worth Soared by an impressive increase of 15.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jay Durga Enzymatic?
In 2019, Jay Durga Enzymatic had a promoter holding of 83.00% and a public holding of 17.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹70.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 7.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jun 2013 | Others | ₹7.00 Cr | Open |
How Many Employees Work at Jay Durga Enzymatic?
Unlock and access historical data on people associated with Jay Durga Enzymatic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jay Durga Enzymatic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jay Durga Enzymatic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
